Skip to main content
Fig. 3 | Molecular Medicine

Fig. 3

From: The role of ERBB4 mutations in the prognosis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors

Fig. 3Fig. 3

Novel nomogram to predict the prognosis of NSCLC patients with ICIs treatment. A The survival curves for patients with ICIs treatment based on the ERBB4 mutational status; B The survival curves for patients with ICIs treatment based on the EGFR mutational status; C The survival curves for patients with ICIs treatment based on PD-L1 expression; D The survival curves for patients with ICIs treatment based on the tumor mutational burden (TMB); E The survival curves for patients with ICIs treatment based on treatment lines; F The survival curves for patients with ICIs treatment based on smoking history; G The novel nomogram based on these variables to predict the prognosis of ICI treatment; H The calibration plot for the nomogram

Back to article page

Molecular Medicine

ISSN: 1528-3658